Since high ADAR1 expression is associated with poorer survival prognoses (Kung et al. 2021; Ramírez-Moya et al. 2020), it is crucial to investigate the ADAR1 prevalence in different cancers to determine which tumors express it more intensively. This evidence concerns the gene ADAR and cancer.